drugset / Trial / NCT00225914
Study of Paxil Use in Menopausal Women
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy, safety, and tolerability of Paroxetine treatment in perimenopausal and postmenopausal women who present with menopause-related symptoms after discontinuing hormone therapy (HT), in the presence or absence of concomitant symptoms of depression or anxiety.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paroxetine | Small molecule | 12.5 mg | — |
| Subject | Paroxetine | Small molecule | 25 mg | — |